FCX vs NDRA · P/E 38, rev $25.45B vs P/E 0.0, $2.6M cap
Freeport-McMoran Copper & Gold Inc (FCX) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
NDRA does not have a complete income-statement cache yet.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the FCX and NDRA stock pages for the full models.
Not investment advice.